Gastrodia and Uncaria Recipe in Treating Stage-one Hypertension: an Evidence-based Optimization Study

PHASE4CompletedINTERVENTIONAL
Enrollment

605

Participants

Timeline

Start Date

October 8, 2019

Primary Completion Date

April 12, 2024

Study Completion Date

April 24, 2024

Conditions
Hypertension
Interventions
DRUG

Gastrodia and Uncaria granule

Patients allocated to the intervention group take 10g of Gastrodia and Uncaria granule each time, twice per day, and for two months.

DRUG

Placebo of Gastrodia and Uncaria granule

Patients allocated to the control group take 10g of placebo of Gastrodia and Uncaria granule each time, twice per day, and for two months. The placebo has similar appearance and smell to genuine drug but has no effective anti-hypertensive agents.

Trial Locations (1)

200025

Ruijin Hospital, Shanghai

All Listed Sponsors
collaborator

Ruijin Hospital

OTHER

collaborator

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

OTHER

lead

Shanghai Institute of Hypertension

OTHER

NCT04035824 - Gastrodia and Uncaria Recipe in Treating Stage-one Hypertension: an Evidence-based Optimization Study | Biotech Hunter | Biotech Hunter